Overexpression of MiR-155-5p and increased number of macrophage population in precancerous prostatic disease
Abstract
Latar Belakang: Gangguan regulasi mikroRNA(miR) dan inflamasi kronik dapat mengubah tumor menjadi karsinoma dan kanker dengan metastasis melalui perubahan seluler dan genomik. Lesi prekanker memiliki peluang 33,3 persen menjadi kanker. Penelitian ini bertujuan untuk mengkaji peran miR-155-5p terhadap mRNA SOCS1 dan populasi makrofag terhadap progresivitas penyakit yang berhubungan dengan Benign Prostate Hyperplasia (BPH), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), dan Prostate Adenocarcinoma (PRAD).
Metode: Penelitian ini merupakan penelitian potong lintang dengan 3 kelompok, yaitu BPH,HGPIN, dan PRAD. Sampel jaringan didapatkan dari Tindakan TURP. Ekspresi miR-155 dianalisis menggunakan qPCR dan dikalkulasi menggunakan metode Livak. Ekspresi mRNA SOCS-1 dianalisis menggunakan reverse transcriptase PCR. Penanda pan makrofag, anti CD-68 monoclonal antibody(MoAb) digunakan untuk mendeteksi populasi makrofag pada jaringan dengan imunohistokimia.
Hasil: Ekspresi miR-155 lebih tinggi pada HGPIN dibandingkan BPH dan PRAD (p=0,14). Ekspresi mRNA SOCS1 pada HGPIN paling rendah diantara ketiga sampel (p=0,96). Terdapat korelasi negative antara miR-155 dan mRNA SOCS1 (p=0,02). Terdapat peningkatan persentase populasi makrofag yang signifikan pada HGPIN (6,03 persen) dibandingkan BPH (0.89 persen) dengan p=0,00.
Kesimpulan: Pada penelitian ini, terdapat perubahan persentase makrofag dan miR-155 pada HGPIN. Variasi ekspresi miR-155 dan persentase populasi makrofag dapat disebabkan karena perubahan epigenetik. Oleh sebab itu, perlu penelitian lebih lanjut untuk memvalidasi hasil tersebut dan memahami kemungkinan menjadi biomarker pada penyakit prekanker pada prostat.
Kata Kunci: Prostatic Intaepithelial Neoplasia, miR-155, Makrofag
Abstract
Background: Impaired microRNA(miR) regulation and chronic inflammation could transform tumors into carcinoma and cancer by metastasis through cellular and genomic changes. Precancerous lesions have a 33.3 percent chance of becoming cancerous. This study investigated the role of miR-155 related to SOCS1 mRNA and macrophage population in disease progression associated with Benign Prostate Hyperplasia (BPH), High-Grade Prostatic Intraepithelial Neoplasia (HGPIN), and Prostate Adenocarcinoma (PRAD).
Methods: This was a cross-sectional study using three groups of samples, namely BPH, HGPIN, and PRAD. Tissue samples were obtained from TURP Action. The expression of miR-155 was analyzed using real-time qPCR and calculated using the Livak method. The expression of SOCS1 mRNA was analyzed using reverse transcriptase PCR. The macrophage pan-marker, anti-CD68 monoclonal antibody (MoAb), was used to detect macrophage population in tissues by immunohistochemistry.
Results: The expression of miR-155 was higher in HGPIN than BPH and PRAD (p=0.14). The expression of SOCS1 mRNA in HGPIN was the lowest among the three samples (p=0.96). There was a negative correlation between miR-155 and SOCS1 mRNA (p=0.02). There was a significant increase in the percentage of the macrophage population in HGPIN (6.03 percent) compared to BPH (0.89 percent) with p=0.00.
Conclusion: In this study, there were changes in the percentage of macrophage and miR-155 in HGPIN. The variation in miR-155 expression and the percentage of the macrophage may be caused by epigenetic changes. Therefore, further research is needed to validate these results and understand the possibility of being a biomarker in precancerous disease of the prostate.
Keywords: Prostatic Intraepithelial Neoplasia, miR-155, Macrophage
References
Komite Penanggulangan Kanker Nasional. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Prostat [Internet]. 2018 [Cited 2020 December 4] ; Available from: http://kanker.kemkes.go.id/guidelines_read.php?id=5&cancer=11
De Nunzio C, Presicce F, Tubaro A. Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol. 2016;13(10):613–26.
Al-dabbagh AA, Mohammad EJ, Jaffal WN. Is high grade prostatic intraepithelial neoplasia a risk factor for prostate cancer ?— a local study. Open J Urol. 2018;8:1–7.
Shiao SL, Chu GCY, Chung LWK. Regulation of prostate cancer progression by the tumor microenvironment. Cancer Lett. 2016;380(1):340–8.
Weagel E, Smith C, Liu PG, O’Neill K. Macrophage polarization and its role in cancer. J Clin Cell Immunol. 2015;6(4):338.
Parisi L, Gini E, Baci D, Tremolati M, Fanuli M, Bassani B, et al. Macrophage polarization in chronic inflammatory diseases: killers or builders? J Immunol Res. 2018;2018:1–25.
Fujii T, Shimada K, Asai O, Tanaka N, Fujimoto K, Hirao K, et al. Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate. Pathobiology. 2013;80:119–26.
Savoca MP, Inferrera A, Verderio EAM, Caccamo D. Search for novel diagnostic biomarkers of prostate inflammation-related disorders : role of transglutaminase isoforms as potential candidates. Mediat Inflamm. 2019;2019:1–10.
Thomas MU, Messex JK, Dang T, Abdulkadir SA, Jorcyk CL, Liou GY. Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK. FEBS J. 2020.
Zhou M. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate. Mod Pathol. 2018;31:71–9.
Lin YH. MicroRNA networks modulate oxidative stress in cancer. Int J Mol Sci. 2019;20(18):4497.
Zhou D, Chen L, Yang K, Jiang H, Xu W, Luan J. SOCS molecules: the growing players in macrophage polarization and function. Oncotarget. 2017;8(36):60710–22.
Hamadi AY, Algehainy NA, Hamdi FY. Molecular implications of microRNA 155 in the pathogenesis of cancer molecular implications of microRNA 155 in the pathogenesis of cancer. int J Gen Can. 2014;1(3&4):46–55.
Kim WT, Kim W. MicroRNAs in prostate cancer. Prostate Int. 2013;1(1):3–9.
Davidsson S, Carlsson J. Prostate cancer and inflammation: the role of miRNAs. EMJ Oncol. 2013;1:56–60.
Curtale G. MiRNAs at the crossroads between innate immunity and cancer : focus on macrophages. Cells. 2018;7(12):1–25.
Cai Z, Chen Q, Chen Y, Gu Me, Zheng D, Zhou J, et al. MicroRNA‑155 promotes the proliferation of prostate cancer cells by targeting annexin 7. Mol Med Rep. 2015;11:533–8.
Zhang J, Li H, Yu J, Wang SE, Ren X. Role of SOCS1 in tumor progression and therapeutic application. Int J Cancer. 2012;130:1971–80.
Hernandez AV, Bobbala D, Kandhi R, Khan MGM, Mayhue M, Dubois CM, et al. SOCS1 inhibits migration and invasion of prostate cancer cells , attenuates tumor growth and modulates the tumor stroma. Prostate Cancer Prostatic Dis. 2016;00:1–12.
Shao N, Ma G, Zhang J, Zhu W. MiR-221-5p enhances cell proliferation and metastasis through post transcriptional regulation of SOCS1 in human prostate cancer. BMC Urol. 2018;18(14):1–9.
Ragusa M, Barbagallo C, Brex D, Caponnetto A, Cirnigliaro M, Battaglia R, et al. Molecular crosstalking among noncoding RNAs : a new network layer of genome regulation in cancer. Int J Genomics. 2017;2017:1–17.
Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321–33.
Kohlhapp FJ, Mitra AK, Lengyel E, Peter ME, Program S. MicroRNA as mediators and communicators between cancer cells and the tumor micro-environment. Oncogene. 2015;34(48):5857–68.
Copyright (c) 2020 Rachma Greta Putri
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
